Cargando…

Linear Immunoglobulin a Bullous Dermatosis in Children

Linear Immunoglobulin A Bullous Disease (LABD) is a rare dermatosis whose pathomechanisms are not yet completely understood. LABD has different features characterizing adults and children in terms of potential triggers, clinical manifestations, and prognosis. The aim of the present study is to revie...

Descripción completa

Detalles Bibliográficos
Autores principales: Mori, Francesca, Saretta, Francesca, Liotti, Lucia, Giovannini, Mattia, Castagnoli, Riccardo, Arasi, Stefania, Barni, Simona, Mastrorilli, Carla, Pecoraro, Luca, Caminiti, Lucia, Marseglia, Gian Luigi, Barbaud, Annick, Novembre, Elio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304959/
https://www.ncbi.nlm.nih.gov/pubmed/35874598
http://dx.doi.org/10.3389/fped.2022.937528
_version_ 1784752208558948352
author Mori, Francesca
Saretta, Francesca
Liotti, Lucia
Giovannini, Mattia
Castagnoli, Riccardo
Arasi, Stefania
Barni, Simona
Mastrorilli, Carla
Pecoraro, Luca
Caminiti, Lucia
Marseglia, Gian Luigi
Barbaud, Annick
Novembre, Elio
author_facet Mori, Francesca
Saretta, Francesca
Liotti, Lucia
Giovannini, Mattia
Castagnoli, Riccardo
Arasi, Stefania
Barni, Simona
Mastrorilli, Carla
Pecoraro, Luca
Caminiti, Lucia
Marseglia, Gian Luigi
Barbaud, Annick
Novembre, Elio
author_sort Mori, Francesca
collection PubMed
description Linear Immunoglobulin A Bullous Disease (LABD) is a rare dermatosis whose pathomechanisms are not yet completely understood. LABD has different features characterizing adults and children in terms of potential triggers, clinical manifestations, and prognosis. The aim of the present study is to review all neonatal and pediatric cases of LABD and summarize the major characteristics. Childhood LABD is mainly idiopathic with a benign prognosis. Neonatal cases are difficult to differentiate from infectious diseases and usually have a poor prognosis. Drugs are one of the possible triggers that can activate autoimmune responses through antigen mimicry and epitope spreading as well as different stimuli (e.g., infections, inflammatory diseases, trauma). The gold standard for the diagnosis is based on direct immunofluorescence. Prognosis is generally favorable but often depends on the prompt dermatological diagnosis, treatment and follow-up guaranteed by a multidisciplinary team, including pediatricians for this group of age.
format Online
Article
Text
id pubmed-9304959
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93049592022-07-23 Linear Immunoglobulin a Bullous Dermatosis in Children Mori, Francesca Saretta, Francesca Liotti, Lucia Giovannini, Mattia Castagnoli, Riccardo Arasi, Stefania Barni, Simona Mastrorilli, Carla Pecoraro, Luca Caminiti, Lucia Marseglia, Gian Luigi Barbaud, Annick Novembre, Elio Front Pediatr Pediatrics Linear Immunoglobulin A Bullous Disease (LABD) is a rare dermatosis whose pathomechanisms are not yet completely understood. LABD has different features characterizing adults and children in terms of potential triggers, clinical manifestations, and prognosis. The aim of the present study is to review all neonatal and pediatric cases of LABD and summarize the major characteristics. Childhood LABD is mainly idiopathic with a benign prognosis. Neonatal cases are difficult to differentiate from infectious diseases and usually have a poor prognosis. Drugs are one of the possible triggers that can activate autoimmune responses through antigen mimicry and epitope spreading as well as different stimuli (e.g., infections, inflammatory diseases, trauma). The gold standard for the diagnosis is based on direct immunofluorescence. Prognosis is generally favorable but often depends on the prompt dermatological diagnosis, treatment and follow-up guaranteed by a multidisciplinary team, including pediatricians for this group of age. Frontiers Media S.A. 2022-07-08 /pmc/articles/PMC9304959/ /pubmed/35874598 http://dx.doi.org/10.3389/fped.2022.937528 Text en Copyright © 2022 Mori, Saretta, Liotti, Giovannini, Castagnoli, Arasi, Barni, Mastrorilli, Pecoraro, Caminiti, Marseglia, Barbaud and Novembre. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pediatrics
Mori, Francesca
Saretta, Francesca
Liotti, Lucia
Giovannini, Mattia
Castagnoli, Riccardo
Arasi, Stefania
Barni, Simona
Mastrorilli, Carla
Pecoraro, Luca
Caminiti, Lucia
Marseglia, Gian Luigi
Barbaud, Annick
Novembre, Elio
Linear Immunoglobulin a Bullous Dermatosis in Children
title Linear Immunoglobulin a Bullous Dermatosis in Children
title_full Linear Immunoglobulin a Bullous Dermatosis in Children
title_fullStr Linear Immunoglobulin a Bullous Dermatosis in Children
title_full_unstemmed Linear Immunoglobulin a Bullous Dermatosis in Children
title_short Linear Immunoglobulin a Bullous Dermatosis in Children
title_sort linear immunoglobulin a bullous dermatosis in children
topic Pediatrics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304959/
https://www.ncbi.nlm.nih.gov/pubmed/35874598
http://dx.doi.org/10.3389/fped.2022.937528
work_keys_str_mv AT morifrancesca linearimmunoglobulinabullousdermatosisinchildren
AT sarettafrancesca linearimmunoglobulinabullousdermatosisinchildren
AT liottilucia linearimmunoglobulinabullousdermatosisinchildren
AT giovanninimattia linearimmunoglobulinabullousdermatosisinchildren
AT castagnoliriccardo linearimmunoglobulinabullousdermatosisinchildren
AT arasistefania linearimmunoglobulinabullousdermatosisinchildren
AT barnisimona linearimmunoglobulinabullousdermatosisinchildren
AT mastrorillicarla linearimmunoglobulinabullousdermatosisinchildren
AT pecoraroluca linearimmunoglobulinabullousdermatosisinchildren
AT caminitilucia linearimmunoglobulinabullousdermatosisinchildren
AT marsegliagianluigi linearimmunoglobulinabullousdermatosisinchildren
AT barbaudannick linearimmunoglobulinabullousdermatosisinchildren
AT novembreelio linearimmunoglobulinabullousdermatosisinchildren